BlackRock Health Sciences Term Trust (NYSE:BMEZ) Shares Acquired by Stifel Financial Corp

Stifel Financial Corp lifted its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 2.2% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 414,346 shares of the company’s stock after buying an additional 8,843 shares during the period. Stifel Financial Corp’s holdings in BlackRock Health Sciences Term Trust were worth $6,563,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Almitas Capital LLC lifted its holdings in shares of BlackRock Health Sciences Term Trust by 89.3% during the 2nd quarter. Almitas Capital LLC now owns 1,761,943 shares of the company’s stock valued at $27,063,000 after acquiring an additional 831,025 shares in the last quarter. Comerica Bank lifted its holdings in shares of BlackRock Health Sciences Term Trust by 31.1% during the 1st quarter. Comerica Bank now owns 15,469 shares of the company’s stock valued at $254,000 after acquiring an additional 3,671 shares in the last quarter. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 11.2% during the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 65,088 shares of the company’s stock valued at $1,000,000 after acquiring an additional 6,565 shares in the last quarter. Dakota Wealth Management lifted its holdings in shares of BlackRock Health Sciences Term Trust by 5.3% during the 2nd quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock valued at $280,000 after acquiring an additional 915 shares in the last quarter. Finally, Blue Bell Private Wealth Management LLC lifted its holdings in shares of BlackRock Health Sciences Term Trust by 37.6% during the 2nd quarter. Blue Bell Private Wealth Management LLC now owns 164,064 shares of the company’s stock valued at $2,520,000 after acquiring an additional 44,866 shares in the last quarter.

BlackRock Health Sciences Term Trust Trading Down 0.1 %

Shares of BMEZ stock opened at 15.48 on Friday. BlackRock Health Sciences Term Trust has a 12 month low of 14.38 and a 12 month high of 16.59. The company’s fifty day moving average price is 15.61 and its two-hundred day moving average price is 15.62.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Monday, December 23rd. Shareholders of record on Monday, December 16th will be issued a $0.1781 dividend. The ex-dividend date of this dividend is Monday, December 16th. This represents a $2.14 dividend on an annualized basis and a yield of 13.81%.

Insiders Place Their Bets

In other news, major shareholder Saba Capital Management, L.P. acquired 15,455 shares of the business’s stock in a transaction on Thursday, September 19th. The shares were purchased at an average price of 16.14 per share, for a total transaction of 249,443.70. Following the acquisition, the insider now directly owns 20,601,568 shares of the company’s stock, valued at 332,509,307.52. This represents a 0.08 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have bought 99,630 shares of company stock worth $1,585,113 in the last quarter.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.